Table 1 Demographic and clinical characteristics of the two study groups
Risk group | P | ||
|---|---|---|---|
Control | At risk | ||
N= | 19 | 17 | - |
Age (years) | 28.3 ± 5.6 | 31.8 ± 5.5 | 0.07 |
Female sex (%) | 47.3 | 58.8 | 0.59 |
Weight (Kg) | 65.4 ± 12.1 | 87.5 ± 21.0 | <0.001 |
Body mass Index (Kg/m2) | 23.0 ± 2.0 | 32.2 ± 5.9 | <0.001 |
Waist circumference (cm) | 78.9 ± 7.5 | 99.1 ± 14.8 | <0.001 |
Waist-to-hip ratio | 0.82 ± 0.06 | 0.87 ± 0.07 | 0.014 |
Whole body fat (%) | 24.2 ± 6.4 | 35.9 ± 7.1 | <0.001 |
Trunk body fat (%) | 23.0 ± 5.8 | 36.7 ± 7.8 | <0.001 |
Systolic blood pressure (mmHg) | 105.4 ± 13.7 | 112.4 ± 9.6 | 0.09 |
Diastolic blood pressure (mmHg) | 67.9 ± 7.5 | 74.7 ± 9.7 | 0.025 |
Fasting plasma glucose (mmol/L) | 4.70 ± 0.32 | 5.25 ± 0.43 | <0.001 |
OGTT 2 h plasma glucose (mmol/L) | 7.03 ± 2.16 | 8.23 ± 2.74 | 0.14 |
Impaired fasting glucose # (%) | 0 (0) | 2 (11.8) | 0.12 |
Impaired glucose tolerance # (%) | 0 (0) | 5 (29.4) | 0.011 |
Glycated hemoglobin A1c (%) | 5.2 ± 0.2 | 5.2 ± 0.7 | 0.6 |
Total cholesterol (mmol/L) | 4.45 ± 0.78 | 4.34 ± 1.04 | 0.74 |
Triglycerides (mmol/L) | 0.84 ± 0.45 | 1.26 ± 0.64 | 0.026 |
HDL cholesterol (mmol/L) | 1.23 ± 0.40 | 1.01 ± 0.25 | 0.067 |
LDL cholesterol (mmol/L) | 2.87 ± 0.71 | 2.91 ± 1.06 | 0.91 |
Triglycerides/HDL cholesterol ratio | 1.78 ± 1.2 | 3.15 ± 1.91 | 0.015 |
Plasma free fatty acids (mEq/L) | 0.42 ± 0.16 | 0.58 ± 0.22 | 0.02 |